4//SEC Filing
Greenstein Leonard M. 4
Accession 0001519692-22-000008
CIK 0001819790other
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 4:24 PM ET
Size
7.1 KB
Accession
0001519692-22-000008
Insider Transaction Report
Form 4
Greenstein Leonard M.
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-10-20$15.90/sh−4,877$77,544→ 54,412 total - Sale
Common Stock
2022-10-20$16.62/sh−123$2,044→ 54,289 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022.
- [F2]The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.49 to $16.45. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $16.58 to $16.77. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001519692
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 4:24 PM ET
- Size
- 7.1 KB